SynthesisPloS one2022

Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for esophageal squamous cell cancer: A meta-analysis.

Yaru Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.